The document outlines Fujifilm Diosynth Biotechnologies' initiatives, focusing on their implementation of the SAP S/4HANA platform at the Hillerød manufacturing site, aimed at enhancing their contract development and manufacturing operations. It discusses the strategic necessity for transitioning from the Biogen Oracle platform, highlights key project management strategies, and emphasizes the importance of a structured and agile approach to ensure success amidst disruptions such as the COVID-19 pandemic. Additionally, it details the planned capacity expansion and ongoing projects, including partnerships to produce medicines for COVID-19.